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Abstract Using digitonin-permeabilised bovine adrenal chro- 
maffin cells, the effects of botulinum neurotoxin light chains on 
exocytosis triggered by Ca 2+ or by GppNHp were examined. 
Botulinum neurotoxin D light chain, prepared as a His6-tagged 
recombinant protein, cleaved VAMP and substantially inhibited 
catecholamine release due to Ca 2+ and GppNHp. Botulinum 
neurotoxin C1 and E light chains produced partial inhibition of 
both Ca 2+- and GppNHp-induced catecholamine release. These 
results suggest that Ca2+-dependent exocytosis and Ca 2+- 
independent exocytosis triggered by a noa-hydrolysable GTP 
analogue occurs via a SNARE-dependent mechanism in chro- 
maffin cells. 
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I. Introduction 
The discovery that clostridial neurotoxins are proteases [I], 
and the characterisation f their specific substrates [2,3], has 
been a major step forward in the identification of proteins 
essential for synaptic neurotransmission. The synaptic vesicle 
protein known either as synaptobrevin or VAMP [4,5] is a 
substrate for tetanus toxin and for botul inum neurotoxins 
B, D, F and G [2,3]. SNAP-25 and syntaxin were originally 
identified as presynaptic membrane proteins [6,7]. SNAP-25 is 
the target for botul inum neurotoxins A and E and syntaxin 
for botul inum neurotoxin C1 [2]. VAMP, syntaxin and 
SNAP-25 are found in a stoichiometric complex in detergent 
extracts of brain membranes and were suggested to function 
as a synaptic vesicle docking complex [8,9] that could act as a 
receptor for a-SNAP and NSF, two proteins with functions in 
multiple vesicular transport pathways [10]. The ability of the 
neurotoxin substrates to bind m-SNAP led to their designation 
as SNAREs (soluble NSF-attachment protein (SNAP) recep- 
tors). A variety of evidence suggests that these various pro- 
teins are key components of the machinery involved in Ca 2+- 
triggered exocytosis in the synapse, though their exact func- 
tions remain a subject of debate [11-13]. 
Clostridial neurotoxins inhibit exocytosis in several endo- 
crine and other secretory cell types. Inhibition of exocytosis in 
a non-neuronal cell by these neurotoxins was first shown for 
adrenal chromaffin cells [14] which have been an important 
model cell for the study of CaZ+-regulated xocytosis [15,16]. 
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Chromaffin cells express all three neurotoxin substrates [17,18] 
which can be isolated in a complex [18] and Ca2+-dependent 
exocytosis in these cells is sensitive to neurotoxins that target 
VAMP (tetanus and botulinum B neurotoxins) [19-24] or 
SNAP-25 (botulinum A and E neurotoxins) [23,25-28]. Insu- 
lin-secreting cells are also sensitive to these two classes of 
neurotoxins [29-31] and studies on these cells have suggested 
that VAMP is essential for Ca2+-induced secretion but not for 
insulin release activated by the non-hydrolysable GTP analo- 
gue, GTPTS, since this was insensitive to tetanus toxin and 
botul inum B neurotoxin [29]. These data on insulin-secreting 
cells, coupled with studies on constitutive vesicle traffic in 
epithelial cells in which basolateral but not apical exocytosis 
is inhibited by botul inum neurotoxins [32], appear to suggest 
that exocytosis could occur by either SNARE-dependent or 
SNARE-independent pathways. Exocytosis in chromaffin cells 
is triggered by Ca 2+ [15,16] but exocytosis can also be acti- 
vated in a CaZ+-independent manner by GTP analogues in 
permeabilised chromaffin cells [33-36]. We have, therefore, 
used botul inum neurotoxins to investigate whether exocytosis 
activated by a non-hydrolysable GTP analogue in permeabi- 
lised chromaffin cells, occurs by a SNARE-dependent mech- 
anism based on sensitivity to recombinant neurotoxin light 
chains. The results show that Ca2+-independent catechola- 
mine release from permeabilised chromaffin cells in response 
to a non-hydrolysable GTP analogue is sensitive to clostridial 
neurotoxins. 
2. Materials and methods 
Bovine adrenal chromaffin cells were dissociated from the adrenal 
medulla and maintained in culture for 3-6 days in 24-well trays as 
previously described [37]. Recombinant botulinum neurotoxins were 
expressed as His6-tagged fusion proteins [38] from plasmids which 
were a generous gift from Dr Heiner Neimann (Tubingen, Germany). 
Proteins were purified from Escherichia coli M15 [pREP4] (Qiagen) 
after induction of expression with 0.5 mM isopropyl-D-thiogalactopyr- 
anoside for 2.5-5 h, cell lysis by ultrasonication a d affinity chroma- 
tography on Ni-NTA-agarose. Proteins were eluted in 20 mM 
HEPES, 200 mM KC1, 2 mM [3-mercaptoethanol, 0.5 mM ATP, 
10% v/v glycerol pH 7.0 using a 50-100 mM imadazole gradient 
generated with a Pharmacia FPLC system and active fractions pooled 
and stored at -20 or -80°C. 
For secretion experiments, chromaffin cells were permeabilised by 
incubation with 20 gM digitonin in permeabilisation buffer (139 mM 
potassium glutamate, 20 mM PIPES, 5 mM EGTA, 2 mM ATP, 2 
mM MgC12, pH6.5) for 10 min, incubated with or without purified 
botulinum neurotoxin light chains (in column elutions buffer or after 
dialysis against permeabilisation buffer) for 25 min in permeabilisa- 
tion buffer and then challenged by addition of permeabilisation buffer 
with no added Ca 2+ (0 Ca 2+, controls), with 10 ktM Ca 2+ or 100 gM 
GppNHp. Catecholamine r leased over a 20 rain period was assayed 
fluorometrically and expressed as a percentage of total cellular cate- 
cholamine [37]. In some experiments, as indicated, ATP was omitted 
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from the final incubation step. All data shown are derived from a 
typical experiment and are expressed as mean + S.E.M. 
For the analysis of protein cleavage by botulinum neurotoxin D, 
cells were taken after a 10 min permeabilisation n digitonin and a 25 
rain incubation with 20 nM neurotoxin, solubilised in SDS dissocia- 
tion buffer, separated on 12.5% SDS-polyacrylamide gels and immu- 
noblots probed with antisera gainst VAMP (a gift from Dr Clifford 
Shone, CAMR, Porton Down, Salisbury), SNAP-25 [18] or syntaxin 
(HPC-1 monoclonal, Sigma Chemical Co.) as previously described 
[18]. 
3. Results and discussion 
The protocol used here was to permeabilise chromaffin cells 
for 10 min using digitonin and then to incubate the cells over 
a further 25 min period, before stimulation with 10 ~tM Ca 2+ 
or 100 BM of the non-hydrolysable GTP analogue guanosine 
5'-[13~/-imido]triphosphate (GppNHp). As shown in Fig. 1, 
GppNHp stimulates catecholamine r lease above basal levels 
in the absence of added Ca 2+ with 5 mM EGTA present. This 
Ca2+-independent secretion triggered by GppNHp, as in pre- 
vious work [33,34], is smaller than that triggered by 10 BM 
Ca 2+ but was reproducibly observed. The release due to 
GppNHp was 2.5 _+ 0.2% of total cellular catecholamine above 
basal from 17 cell batches. This extent of release could con- 
ceivably be accounted for by release of only docked secretory 
granules (corresponding to 1.5-3% of total granules per cell 
[15,39]). This is potentially of importance since it has been 
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Fig. 1. Catecholamine r lease stimulated by Ca 2+ or GppNHp and 
requirement for ATP. Chromaffin cells were permeabilised with digi- 
tonin for 10 min, incubated for a further 25 min and then chal- 
lenged with 0 Ca 2+, 10 BM Ca 2+ or 0 Ca 2+ plus 100 gM GppNHp 
in the presence or absence of ATP (n = 6 in each case). Catechola- 
mine release over a 20 min period was assayed and expressed as a 
percentage of total cellular catecholamine. The catecholamine r - 
leased in response to 10 BM Ca 2+ or GppNHp is shown as release 
above basal (0 Ca 2+) levels. 






Fig. 2. Cleavage of VAMP in penneabilised chromaffin cells by bo- 
tulinum neurotoxin D light chain. After digitonin-permeabilisation, 
chromaffin ceils were treated with or without 20 nM His6-tagged 
light chain of botulinum neurotoxin D (BoNT D) for 25 min. The 
cells were analysed by SDS-polyacryamide g lelectrophoresis and 
immunoblotting with antisera gainst VAMP, SNAP-25 or syntaxin 
as indicated. VAMP was cleaved by 62% by botulinum neuroto~n 
D in this experiment. 
not be accessible to neurotoxins [38]. It has been suggested 
that release of docked granules corresponds to that compo- 
nent of release that is MgATP-independent [39]. Release of 
catecholamine due to GppNHp was, however, reduced by 
about 50% in the absence of ATP, as is the case for Ca 2÷- 
induced release (Fig. 1) indicating that the limited extent of 
GppNHp-induced release cannot be explained on the basis of 
specific release of docked, ATP-independent granules. 
In order to examine the sensitivity of Ca 2+- and GppNHp- 
induced release to clostridial neurotoxins, we introduced the 
active light chains into the permeabilised cells in the incuba- 
tion preceding stimulation. The neurotoxin light chains were 
expressed and purified as His6-tagged recombinant proteins in 
E. coli which would avoid any potential problems due to 
contamination f the neurotoxins with other types of clostri- 
dial toxins. The recombinant light chain of botulinum D neu- 
rotoxin (20 nM) was found to cleave VAMP leading to a loss 
of around 60% of VAMP detected by immunoblotting and 
had no effect on levels of syntaxin on SNAP-25, after incuba- 
tion with permeabilised cells (Fig. 2), consistent with data on 
neuronal preparations showing that this neurotoxin specifi- 
cally cleaves VAMP [40,41]. Treatment of permeabilised cells 
with botulinum D neurotoxin light chain led to a substantial 
inhibition of both Ca 2+- and GppNHp-induced catechola- 
mine release (Fig. 3). This neurotoxin light chain, at 20 nM, 
produced a greater than 50% inhibition in all 11 experiments 
with Ca2+-induced release and a mean inhibition of 
74.1_+9.2% in 7 separate xperiments with GppNHp as the 
stimulus. As shown in Fig. 3, at higher neurotoxin D light 
chain concentrations release due to GppNHp was abolished. 
These results suggest, therefore, that VAMP is involved not 
only in Ca2÷-induced release in chromaffin cells but also in 
release induced by GppNHp. Direct analysis of membrane 
capacitance has directly shown that GppNHp induces exocy- 
tosis [36] and it is likely that the same final steps in the exo- 
cytotic pathway are activated by Ca 2+ or by GppNHp. Pre- 
vious work on insulin-secreting cells had shown that secretion 
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induced by GTPTS was insensitive to tetanus and botulinum B 
neurotoxins despite extensive cleavage of VAMP, and inhibi- 
tion of Ca2+-induced secretion, leading to the suggestion that 
VAMP is essential for the CaZ+-induced secretion but not that 
induced by non-hydrolysable GTP analogues [29]. The present 
data from chromaffin cells show, in contrast, that both stimuli 
are neurotoxin D-sensitive and therefore act via a VAMP- 
dependent pathway. 
The requirement for the other two neurotoxin sensitive sub- 
strates for secretion due to Ca 2+ or GppNHp in chromaffin 
cells was examined using recombinant light chains of the bo- 
tulinum C1 neurotoxin, which was shown to preferentially 
cleave syntaxin [42,43] and E neurotoxin which cleaves 
SNAP-25 [44,45]. The maximum concentration of these light 
chains that could be used was limited by their instability fol- 
lowing dialysis. Both neurotoxins produced partial inhibition 
of Ca2+-induced release. A similar partial inhibition was also 
seen for GppNHp-induced release (Fig. 4) of 59.3 + 9.4% (n=6 
experiments) for botulinum neurotoxin C1 and 58.8 + 14.0% 
(n=4 experiments) for neurotoxin E compound to control val- 
ues. 
As far as is currently known, botulinum neurotoxin D 
cleaves only VAMP 1 and VAMP 2 and the ubiquitous homo- 
logue cellubrevin [2]. We have shown here that recombinant 
His6-tagged botulinum neurotoxin D light chain cleaves 
VAMP but not syntaxin or SNAP-25 in permeabilised chro- 
maffin cells and substantially inhibits both Ca2+-induced and 
GppNHp-induced catecholamine release suggesting that one 
or more VAMPs are essential in both cases. This differs from 
the situation in insulin-secreting cells where it has been sug- 
gested that VAMPs are not required for GTPTS-induced se- 
cretion [29]. While botulinum neurotoxin E is believed to be 
specific for SNAP-25, neurotoxin C1 has recently been shown 
to cleave both syntaxin and SNAP-25 in chromaffin cells [46]. 
Nevertheless, the data from the three neurotoxin light chain 
used here are consistent with a role for the SNARE proteins 
in GppNHp-induced secretion in chromaffin cells. 
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Fig. 3. Effect of botulinum neurotoxin D light chain on catechola- 
mine release due to Ca 2+ or GppNHp. After digitonin-permeabilisa- 
tion for 10 min, cells were incubated for 25 min with the indicated 
concentration of His6-tagged botulinum neurotoxin D light chain 
(BoNT D). The cells were then challenged with 0 Ca 2+, 10 laM 
Ca 2+ or 0 Ca 2+ plus 100 l.tM GppNHp and catecholamine r lease 
over a 20 min period assayed and expressed as a percentage of total 
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Fig. 4. Effect of botulinum neurotoxin C1 and E light chains on ca- 
techolamine release due to Ca 2+ or GppNHp. After digitonin-per- 
meabilisation for 10 rain, cells were incubated for 25 min with no 
additions, with 60 nM His6-tagged botulinum neurotoxin C1 light 
chain (BoNT C1) or with 10 nM His6-tagged botulinum neurotoxin 
E light chain (BoNT E). The cells were then challenged with 0 
Ca 2+, 10 ~tM Ca 2+ or 0 Ca 2+ plus 100 ~tM GppNHp and catechola- 
mine release over a 20 min period assayed and expressed as a per- 
centage of total cellular catecholamine (n = 4 in each case). The cate- 
cholamine release in response to 10/aM Ca 2+ or GppNHp is shown 
as release above basal (0 Ca 2+) levels. 
Various GTP analogues have multiple effects on secretion 
from permeabilised chromaffin cells [47] which includes stimu- 
lation of  release from permeabilised cells [33-35] and exocyto- 
sis in patch-clamped cells [36] by GppNHp at very low free 
Ca 2+ concentrations. Like Ca2+-induced secretion, Ca2+-inde - 
pendent catecholamine r lease stimulated by GppNHp is par- 
tially MgATP-dependent, is substantially inhibited by prior 
treatment with botulinum neurotoxin D and is partially in- 
hibited by neurotoxins C1 and E. These results suggest hat 
both activators of exocytosis activate a common mechanism 
leading to exocytosis that requires the SNARE proteins, 
VAMP, syntaxin and SNAP-25 and would argue against the 
presence of a SNARE-independent pathway for exocytosis in 
adrenal chromaffin cells. 
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